SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0650+0.2%12:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dirkdiggler who wrote (12014)6/7/2013 9:04:32 AM
From: NTTG3 Recommendations

Recommended By
boomertree2
PJr
Pogeu Mahone

   of 13111
 
You were originally suppose to see the PIII trial start in 2011 if you go back and look at the 2010 ASCO poster....they have successfully strung investors along for 3+ years now with that rumor

PVCT is now into business plan 'C' to secure funding going forward:

PVCT plan A was to generate enough data to secure a comprehensive big pharma business development partner through a traditional agreement with up front and milestone payments......no luck so far, low prospects going forward

PVCT plan B was to go into bigger stock markets (NASDAQ) to shore up investor driven cash resources.... first attempt crashed and burned badly, doubt they will go back to that well anytime soon

PVCT plan C is to pursue regional deals, not unlike their old approach to investment funds....lots of work and cash spend for a nominal ROI....and most of the regions being discussed are likely interested in HCC, which puts PV-10 development cash support back to support for PI studies

How long till plan D begins to materialize?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext